GRANT Life Sciences, Inc.
Grant Life Sciences, Inc. (GLS) is a developmental stage company, engaged in the research, development, marketing, and sale of diagnostic kits for the screening, monitoring, and diagnosis of low grade cervical disease. It is developing blood based screening tests to screen woman for cervical cancer and pre-cancerous conditions. Additionally it provides Malaria rapid diagnostic tests, rapid tests for Dengue Fever, HIV-1 and HIV-2 which is licensed from AccuDx Corporation. GLS owns the exclusive rights to the rapid tests developed by AccuDx Corporation. The company is headquartered in Los Angeles, California, the US.